Keros Therapeutics, Inc. (KROS)
11.95
+0.31
(+2.66%)
USD |
NASDAQ |
Oct 09, 16:00
11.95
0.00 (0.00%)
Pre-Market: 09:25
Keros Therapeutics Market Cap : 236.94M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 236.94M |
| October 08, 2026 | 230.79M |
| October 07, 2026 | 222.26M |
| October 06, 2026 | 218.30M |
| October 05, 2026 | 228.41M |
| October 02, 2026 | 225.24M |
| October 01, 2026 | 223.25M |
| September 30, 2026 | 226.03M |
| September 29, 2026 | 221.87M |
| September 28, 2026 | 223.65M |
| September 25, 2026 | 230.39M |
| September 24, 2026 | 229.00M |
| September 23, 2026 | 230.59M |
| September 22, 2026 | 232.57M |
| September 21, 2026 | 227.62M |
| September 18, 2026 | 221.87M |
| September 17, 2026 | 225.24M |
| September 16, 2026 | 212.94M |
| September 15, 2026 | 221.47M |
| September 14, 2026 | 222.26M |
| September 11, 2026 | 219.69M |
| September 10, 2026 | 221.47M |
| September 09, 2026 | 224.25M |
| September 08, 2026 | 221.47M |
| September 04, 2026 | 224.44M |
| Date | Value |
|---|---|
| September 03, 2026 | 220.28M |
| September 02, 2026 | 222.66M |
| September 01, 2026 | 219.49M |
| August 31, 2026 | 219.69M |
| August 28, 2026 | 218.69M |
| August 27, 2026 | 222.66M |
| August 26, 2026 | 220.48M |
| August 25, 2026 | 231.58M |
| August 24, 2026 | 213.74M |
| August 21, 2026 | 218.69M |
| August 20, 2026 | 217.11M |
| August 19, 2026 | 220.08M |
| August 18, 2026 | 210.37M |
| August 17, 2026 | 207.79M |
| August 14, 2026 | 200.25M |
| August 13, 2026 | 211.36M |
| August 12, 2026 | 222.06M |
| August 11, 2026 | 210.96M |
| August 10, 2026 | 211.95M |
| August 07, 2026 | 221.07M |
| August 06, 2026 | 211.16M |
| August 05, 2026 | 198.17M |
| August 04, 2026 | 203.23M |
| August 03, 2026 | 200.45M |
| July 31, 2026 | 199.66M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Incyte Corp. | 22.67B |
| Viking Therapeutics, Inc. | 3.326B |
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.12B |
| Anika Therapeutics, Inc. | 262.04M |
Market Cap Related Metrics
| PS Ratio | 21.34 |
| Price to Book Value | 0.9032 |
| Price | 11.95 |
| Earnings Yield | -30.96% |